Sajad Khiali

Dr. Sajad Khiali


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2018 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
SKSajad Khiali
Sajad Khiali
AGAfshin Gharekhani
Afshin Gharekhani
TETaher Entezari-Maleki
Taher Entezari-Maleki
Purpose: Isotretinoin is the most effective anti-acne drug with a long-term remission. However; it contains severe teratogenic effects with serious adverse drug reactions, which limits the use of medication. Methods: To review the use of isotretinoin during pregnancy, we carried out a comprehensive search of literature in Google Scholar, Scopus and PubMed/Medline from their inception until April 2015. Results: Database searching identified 277 records, of which, 38 articles were retrieved according to abstract and title assessment. After full-text review, 17 articles were excluded and finally, a total of 21 studies met the inclusion criteria. Data showed an increased pattern in the use of isotretinoin. In some studies, health care providers were not fully adhered to the risk reduction programs in pregnancy. Exposing to isotretinoin among pregnant women has still occurred due to detrimental adherence to risk reduction programs which resulted in live-born infants with different kinds of abnormalities. Conclusion: Despite the known serious adverse effect of isotretinoin, the use of drug was not based on the guidelines in some cases, which needs more attentions to prevent the severe drug related problems.

24 February 2022 in Future Microbiology
Verified
Journal Article
Open access
SKSajad Khiali
Sajad Khiali
EKElnaz Khani
Elnaz Khani
SRSamineh B Rouy
Samineh B Rouy
TETaher Entezari-Maleki
Taher Entezari-Maleki
Despite the progress in the management of COVID-19, effective oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in the management of C...

2 August 2023 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
SKSajad Khiali
Sajad Khiali
MTMohammadreza Taban‐Sadeghi
Mohammadreza Taban‐Sadeghi
PSParvin Sarbakhsh
Parvin Sarbakhsh
NKNaser Khezerlouy‐Aghdam
Naser Khezerlouy‐Aghdam
ARAfra Rezagholizadeh
Afra Rezagholizadeh
TETaher Entezari-Maleki
Taher Entezari-Maleki

30 March 2023 in Pharmaceutical Medicine
Verified
Journal Article
Closed access
PDF file
SKSajad Khiali
Sajad Khiali
AAAmin Agabalazadeh
Amin Agabalazadeh
HSHadi Sahrai
Hadi Sahrai
HBHossein Bannazadeh Baghi
Hossein Bannazadeh Baghi
GBGholamreza Rahbari Banaeian
Gholamreza Rahbari Banaeian
TETaher Entezari-Maleki
Taher Entezari-Maleki

26 March 2022 in BioImpacts
Verified
Journal Article
Open access
SKSajad Khiali
Sajad Khiali
ARAfra Rezagholizadeh
Afra Rezagholizadeh
TETaher Entezari-Maleki
Taher Entezari-Maleki
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.

1 January 2020 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
SKSajad Khiali
Sajad Khiali
TETaher Entezari-Maleki
Taher Entezari-Maleki